source
- Celcuity reports positive Phase 3 data for gedatolisib, bolstering broader approval prospectsCelcuity announced new data from an ongoing Phase 3 trial of its experimental breast cancer drug gedatolisib. The data showed that two- and three-drug combinations that included gedatolisib delaye…
- AI drug repurposing in oncology hampered by fragmented data, curated knowledge neededAI tools are being used to look for new cancer indications for existing biologics, but the article notes that fragmented and disparate data sets limit even the most advanced models. Repurposing pr…